首页 > 最新文献

Journal of the ASEAN Federation of Endocrine Societies最新文献

英文 中文
Clinical Profile of Non-thyroidal Cancer Patients with Tyrosine Kinase Inhibitor-induced Thyroid Dysfunction in the University of Santo Tomas Hospital, Philippines: A 5-Year Single-center Retrospective Study. 菲律宾圣托马斯大学医院酪氨酸激酶抑制剂诱导甲状腺功能障碍的非甲状腺癌患者的临床概况:一项5年单中心回顾性研究。
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-09-05 DOI: 10.15605/jafes.039.02.14
Nenuel Angelo Luna, Jennilyn Quinitio, Erick Mendoza, Sjoberg Kho, Priscilla Caguioa

Objectives: This study aimed to determine the clinical profile of non-thyroidal cancer patients with thyroid dysfunction associated with tyrosine kinase inhibitor (TKI) therapy at the University of Santo Tomas Hospital (USTH), Philippines.

Methodology: This is a retrospective observational study of TKI-initiated adult non-thyroidal cancer patients with thyroid function testing from 2013 to 2018.

Results: Forty percent (95% CI: 26.2% - 58.61%) of the sixty individuals who had thyroid function tests (TFT) had incident thyroid dysfunction. Thirty percent had hypothyroidism (i.e., 25% overt [mean TSH 16.64 uIU/mL]; 5% subclinical [mean TSH 6.62 uIU/mL]). The median time at risk was 8 and 16 months for overt and subclinical hypothyroidism, respectively. Fifty-six percent had persistent hypothyroidism (median TSH 16.75, p = 0.009). The average time to recovery of transient hypothyroidism was 39 months. Ten percent had hyperthyroidism with a median time at risk of 1.5 months. Non-small cell lung cancer and renal cell carcinoma were possible associated risk factors of thyroid dysfunction.

Conclusion: TKI-induced thyroid dysfunctions are common. Screening and monitoring for thyroid abnormalities during TKI therapy is important.

目的:本研究旨在确定菲律宾圣托马斯大学医院(USTH)非甲状腺癌患者与酪氨酸激酶抑制剂(TKI)治疗相关的甲状腺功能障碍的临床概况。方法:本研究是一项回顾性观察性研究,研究对象为2013 - 2018年tki引发的甲状腺功能检测的成人非甲状腺癌患者。结果:60例甲状腺功能检查(TFT)患者中有40% (95% CI: 26.2% - 58.61%)发生偶发甲状腺功能障碍。30%的患者有甲状腺功能减退(即25%为显性[平均TSH 16.64 uIU/mL];5%亚临床[平均TSH 6.62 uIU/mL])。明显和亚临床甲状腺功能减退的中位风险时间分别为8个月和16个月。56%的患者有持续性甲状腺功能减退(中位TSH 16.75, p = 0.009)。短暂性甲状腺功能减退平均恢复时间为39个月。10%的患者患有甲亢,平均患病时间为1.5个月。非小细胞肺癌和肾细胞癌可能是甲状腺功能障碍的相关危险因素。结论:tki所致甲状腺功能障碍较为常见。TKI治疗期间甲状腺异常的筛查和监测是重要的。
{"title":"Clinical Profile of Non-thyroidal Cancer Patients with Tyrosine Kinase Inhibitor-induced Thyroid Dysfunction in the University of Santo Tomas Hospital, Philippines: A 5-Year Single-center Retrospective Study.","authors":"Nenuel Angelo Luna, Jennilyn Quinitio, Erick Mendoza, Sjoberg Kho, Priscilla Caguioa","doi":"10.15605/jafes.039.02.14","DOIUrl":"https://doi.org/10.15605/jafes.039.02.14","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to determine the clinical profile of non-thyroidal cancer patients with thyroid dysfunction associated with tyrosine kinase inhibitor (TKI) therapy at the University of Santo Tomas Hospital (USTH), Philippines.</p><p><strong>Methodology: </strong>This is a retrospective observational study of TKI-initiated adult non-thyroidal cancer patients with thyroid function testing from 2013 to 2018.</p><p><strong>Results: </strong>Forty percent (95% CI: 26.2% - 58.61%) of the sixty individuals who had thyroid function tests (TFT) had incident thyroid dysfunction. Thirty percent had hypothyroidism (i.e., 25% overt [mean TSH 16.64 uIU/mL]; 5% subclinical [mean TSH 6.62 uIU/mL]). The median time at risk was 8 and 16 months for overt and subclinical hypothyroidism, respectively. Fifty-six percent had persistent hypothyroidism (median TSH 16.75, <i>p</i> = 0.009). The average time to recovery of transient hypothyroidism was 39 months. Ten percent had hyperthyroidism with a median time at risk of 1.5 months. Non-small cell lung cancer and renal cell carcinoma were possible associated risk factors of thyroid dysfunction.</p><p><strong>Conclusion: </strong>TKI-induced thyroid dysfunctions are common. Screening and monitoring for thyroid abnormalities during TKI therapy is important.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"20-26"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiologic Profile and Clinical Outcomes of Patients with Pheochromocytoma at the University of the Philippines Philippine General Hospital (UP-PGH). 菲律宾大学菲律宾总医院嗜铬细胞瘤患者的流行病学概况和临床结果
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-09-09 DOI: 10.15605/jafes.039.02.18
Edrome Hernandez, Cecilia Jimeno, Elizabeth Paz-Pacheco

Objective: This study aims to describe the epidemiologic profile and determine the clinical outcomes of patients with pheochromocytoma at the University of the Philippines Philippine General Hospital (UP-PGH).

Methodology: We reviewed the medical records of 30 patients with histopathology-proven, clinical, and biochemical diagnosis of pheochromocytoma. Demographic, clinical characteristics, and clinical outcomes were collected for each patient.

Results: The median age at diagnosis of pheochromocytoma was 37.5 years (IQR 28-55) and the most common metabolic comorbidities were glucose intolerance (60%) and hypertriglyceridemia (23.3%). Majority of the patients were hypertensive (90%). Two third of the patients presented with classic features of pheochromocytoma while the remaining third presented as adrenal incidentaloma. Recurrence was found in 17% of subjects, who were significantly younger (25 years vs 46.5 years P = 0.0229), and had higher rates of bilateral pheochromocytoma (0 vs 75%), p = 0.002). Metastatic pheochromocytoma was found in 10% of the subjects.

Conclusion: Our study demonstrated that patients with pheochromocytoma in our setting exhibit great variability in terms of clinical behavior. Although majority of the patients presented with symptoms related to catecholamine excess, almost one-third of the patients were only incidentally discovered. Incidence of pheochromocytoma recurrence and metastasis in our setting are comparable with current available foreign studies.

目的:本研究旨在描述菲律宾大学菲律宾总医院(UP-PGH)嗜铬细胞瘤患者的流行病学概况并确定其临床结局。方法:我们回顾了30例经组织病理学证实、临床和生化诊断为嗜铬细胞瘤的患者的医疗记录。收集每位患者的人口学、临床特征和临床结果。结果:嗜铬细胞瘤诊断时的中位年龄为37.5岁(IQR 28-55),最常见的代谢合并症是葡萄糖耐受不良(60%)和高甘油三酯血症(23.3%)。大多数患者为高血压(90%)。三分之二的患者表现为嗜铬细胞瘤的典型特征,而剩下的三分之一表现为肾上腺偶发瘤。17%的患者复发率明显较年轻(25岁vs 46.5岁P = 0.0229),双侧嗜铬细胞瘤发生率较高(0 vs 75%, P = 0.002)。在10%的受试者中发现转移性嗜铬细胞瘤。结论:我们的研究表明,嗜铬细胞瘤患者在临床行为方面表现出很大的变异性。虽然大多数患者表现出与儿茶酚胺过量有关的症状,但几乎三分之一的患者只是偶然发现的。嗜铬细胞瘤复发和转移的发生率在我们的设置是相当的,目前可获得的国外研究。
{"title":"Epidemiologic Profile and Clinical Outcomes of Patients with Pheochromocytoma at the University of the Philippines Philippine General Hospital (UP-PGH).","authors":"Edrome Hernandez, Cecilia Jimeno, Elizabeth Paz-Pacheco","doi":"10.15605/jafes.039.02.18","DOIUrl":"https://doi.org/10.15605/jafes.039.02.18","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to describe the epidemiologic profile and determine the clinical outcomes of patients with pheochromocytoma at the University of the Philippines Philippine General Hospital (UP-PGH).</p><p><strong>Methodology: </strong>We reviewed the medical records of 30 patients with histopathology-proven, clinical, and biochemical diagnosis of pheochromocytoma. Demographic, clinical characteristics, and clinical outcomes were collected for each patient.</p><p><strong>Results: </strong>The median age at diagnosis of pheochromocytoma was 37.5 years (IQR 28-55) and the most common metabolic comorbidities were glucose intolerance (60%) and hypertriglyceridemia (23.3%). Majority of the patients were hypertensive (90%). Two third of the patients presented with classic features of pheochromocytoma while the remaining third presented as adrenal incidentaloma. Recurrence was found in 17% of subjects, who were significantly younger (25 years vs 46.5 years P = 0.0229), and had higher rates of bilateral pheochromocytoma (0 vs 75%), p = 0.002). Metastatic pheochromocytoma was found in 10% of the subjects.</p><p><strong>Conclusion: </strong>Our study demonstrated that patients with pheochromocytoma in our setting exhibit great variability in terms of clinical behavior. Although majority of the patients presented with symptoms related to catecholamine excess, almost one-third of the patients were only incidentally discovered. Incidence of pheochromocytoma recurrence and metastasis in our setting are comparable with current available foreign studies.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"41-47"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Acute Coronary Syndrome Risk in Medically Managed Subjects with Type 2 Diabetes Mellitus - Is the ASCVD Risk Score Failing Here? 接受药物治疗的 2 型糖尿病患者的急性冠状动脉综合征风险--ASCVD 风险评分是否失效?
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-02-05 DOI: 10.15605/jafes.039.01.15
Ameya Joshi, Harminder Singh, Sanjay Kalra

Objectives: Type 2 Diabetics have elevated risk for acute coronary syndrome (ACS). The current management algorithm focuses on atherosclerotic cardiovascular (ASCVD) risk score to stratify this risk. However, in medically managed subjects, this algorithm may not be accurate. This study compares the ASCVD risk score in an Indian population with T2DM under medical supervision and the actual incidence of ACS. It also compared the ASCVD risk scores in cases with T2DM who developed ACS to controls and tried to estimate whether the ASCVD risk score is different in the two subsets, evaluating the utility of the ASCVD risk score in predicting ACS.

Methodology: This is an electronic medical record (EMR) based case-control study. Only records of subjects with T2DM where details of age, sex, body mass index, blood pressure, duration of diabetes, family history of ACS, lipid profile, renal and liver function tests were included. The incidence of ACS was calculated in the selected records, and the records of subjects with ACS were compared with age and sex-matched subjects without ACS. Data are summarized as median and interquartile range (IQR). Wilcoxon rank-sum test was used for checking differences in continuous variables and Pearson's Chi-squared test for categorical data. Univariate and multivariate logistic regression analyses were used to check the effect of ASCVD scores and other variables on the occurrence of ACS.Statistical data analyses were performed using JASP, version 0.16.4 (JASP Team [2022]) for MS Windows.

Results: Of the 1226 EMRs included in the analysis, 207 had ACS. The actual incidence of ACS was 16.85% in 6 years, higher than the mean predicted 10-year incidence of 14.56 percent (p <0.05). The cases were age and sex-matched with controls and the ASCVD incidence was estimated in the two groups. The mean ASCVD score in the cases was 14.565 ± 8.709 (Min: 1.5, Max: 38.3) and controls 13.114 ± 8.247 (Min: 1.4, Max: 45). The chance of development of ACS increases with elevated systolic blood pressure (per mmHg rise OR: 1.04, 95% CI: 1.03, 1.06; p <0.001), positive family history (OR: 5.70, 95% CI: 3.41, 9.77; p <0.001), statin use (OR: 2.26, 95% CI: 1.46, 3.52; p <0.001), and longer duration of diabetes (for every year increase OR: 1.19, 95% CI: 1.13, 1.25; p <0.001).

Conclusion: The ASCVD risk score underestimates the ACS risk in subjects with T2DM under medical supervision and may not differ in those who developed and did not develop ACS. We also conclude that factors like a negative family history (30% less risk), longer duration of diabetes, and higher SBP are relevant in those who developed ACS.

目标:2 型糖尿病患者罹患急性冠状动脉综合征(ACS)的风险较高。目前的管理算法主要通过动脉粥样硬化性心血管疾病(ASCVD)风险评分来对这一风险进行分层。然而,对于接受药物管理的受试者来说,这种算法可能并不准确。本研究比较了在医疗监护下的印度 T2DM 患者的 ASCVD 风险评分和 ACS 的实际发病率。研究还比较了发生 ACS 的 T2DM 病例与对照组的 ASCVD 风险评分,并试图估算这两个子集的 ASCVD 风险评分是否不同,评估 ASCVD 风险评分在预测 ACS 方面的效用:这是一项基于电子病历(EMR)的病例对照研究。只纳入了 T2DM 受试者的记录,其中包括年龄、性别、体重指数、血压、糖尿病持续时间、ACS 家族史、血脂概况、肾功能和肝功能检查等详细信息。计算所选记录中的心肌梗死发病率,并将心肌梗死患者的记录与年龄和性别匹配的无心肌梗死患者的记录进行比较。数据以中位数和四分位数间距(IQR)汇总。连续变量的差异采用 Wilcoxon 秩和检验,分类数据采用 Pearson's Chi-squared 检验。采用单变量和多变量逻辑回归分析来检验ASCVD评分和其他变量对ACS发生率的影响。统计数据分析采用MS Windows的JASP 0.16.4版(JASP Team [2022]):结果:在纳入分析的 1226 份 EMR 中,有 207 份发生了 ACS。6年内ACS的实际发病率为16.85%,高于平均预测的10年发病率14.56%(p p p p p p p 结论):ASCVD 风险评分低估了在医疗监护下的 T2DM 患者的 ACS 风险,而且在发生和未发生 ACS 的患者中可能没有差异。我们还得出结论,阴性家族史(风险降低 30%)、糖尿病病程较长和 SBP 较高等因素与发生 ACS 的患者有关。
{"title":"The Acute Coronary Syndrome Risk in Medically Managed Subjects with Type 2 Diabetes Mellitus - Is the ASCVD Risk Score Failing Here?","authors":"Ameya Joshi, Harminder Singh, Sanjay Kalra","doi":"10.15605/jafes.039.01.15","DOIUrl":"10.15605/jafes.039.01.15","url":null,"abstract":"<p><strong>Objectives: </strong>Type 2 Diabetics have elevated risk for acute coronary syndrome (ACS). The current management algorithm focuses on atherosclerotic cardiovascular (ASCVD) risk score to stratify this risk. However, in medically managed subjects, this algorithm may not be accurate. This study compares the ASCVD risk score in an Indian population with T2DM under medical supervision and the actual incidence of ACS. It also compared the ASCVD risk scores in cases with T2DM who developed ACS to controls and tried to estimate whether the ASCVD risk score is different in the two subsets, evaluating the utility of the ASCVD risk score in predicting ACS.</p><p><strong>Methodology: </strong>This is an electronic medical record (EMR) based case-control study. Only records of subjects with T2DM where details of age, sex, body mass index, blood pressure, duration of diabetes, family history of ACS, lipid profile, renal and liver function tests were included. The incidence of ACS was calculated in the selected records, and the records of subjects with ACS were compared with age and sex-matched subjects without ACS. Data are summarized as median and interquartile range (IQR). Wilcoxon rank-sum test was used for checking differences in continuous variables and Pearson's Chi-squared test for categorical data. Univariate and multivariate logistic regression analyses were used to check the effect of ASCVD scores and other variables on the occurrence of ACS.Statistical data analyses were performed using JASP, version 0.16.4 (JASP Team [2022]) for MS Windows.</p><p><strong>Results: </strong>Of the 1226 EMRs included in the analysis, 207 had ACS. The actual incidence of ACS was 16.85% in 6 years, higher than the mean predicted 10-year incidence of 14.56 percent (<i>p</i> <0.05). The cases were age and sex-matched with controls and the ASCVD incidence was estimated in the two groups. The mean ASCVD score in the cases was 14.565 ± 8.709 (Min: 1.5, Max: 38.3) and controls 13.114 ± 8.247 (Min: 1.4, Max: 45). The chance of development of ACS increases with elevated systolic blood pressure (per mmHg rise OR: 1.04, 95% CI: 1.03, 1.06; <i>p</i> <0.001), positive family history (OR: 5.70, 95% CI: 3.41, 9.77; <i>p</i> <0.001), statin use (OR: 2.26, 95% CI: 1.46, 3.52; <i>p</i> <0.001), and longer duration of diabetes (for every year increase OR: 1.19, 95% CI: 1.13, 1.25; <i>p</i> <0.001).</p><p><strong>Conclusion: </strong>The ASCVD risk score underestimates the ACS risk in subjects with T2DM under medical supervision and may not differ in those who developed and did not develop ACS. We also conclude that factors like a negative family history (30% less risk), longer duration of diabetes, and higher SBP are relevant in those who developed ACS.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"31-36"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric Acid Crystalluria following the Recovery Phase of Diabetic Ketoacidosis (DKA): A Lesser-known Complication of DKA. 糖尿病酮症酸中毒(DKA)恢复阶段的尿酸结晶尿:糖尿病酮症酸中毒恢复期的尿酸结晶:一种鲜为人知的并发症
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-05-05 DOI: 10.15605/jafes.039.01.20
Yotsapon Thewjitcharoen, Nopparath Tongpoo, Worawit Kittipoom
{"title":"Uric Acid Crystalluria following the Recovery Phase of Diabetic Ketoacidosis (DKA): A Lesser-known Complication of DKA.","authors":"Yotsapon Thewjitcharoen, Nopparath Tongpoo, Worawit Kittipoom","doi":"10.15605/jafes.039.01.20","DOIUrl":"10.15605/jafes.039.01.20","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"129-130"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Osteitis Fibrosa Cystica of the Mandible: A Rare Presentation during Pregnancy due to CDC73 Mutation. 1例下颌骨纤维性囊性骨炎:因CDC73突变引起的罕见妊娠表现。
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-09-03 DOI: 10.15605/jafes.039.02.17
Pratibha Pawal, Anand Nikalje, Yash Chauhan, Premlata Varthakavi, Nikhil Bhagwat

Typically, primary hyperparathyroidism (PHPT) develops as a result of multiglandular hyperplasia, parathyroid cancer, or parathyroid adenoma. Patients usually present with skeletal manifestations such as low-trauma fractures. Osteitis fibrosa cystica (OFC) is a classic yet rare skeletal manifestation of advanced PHPT currently reported in less than 2% of patients. We present a case of a 29-year-old Indian female who presented with a femur fracture and mandibular OFC 20 days after delivery. The painless mandibular swelling gradually progressed from the third month of pregnancy. The biochemical and radiological investigations were indicative of PHPT-associated OFC. After the excision of the three-and-a-half parathyroid gland, histology revealed benign cystic adenomas and hyperplasia. Based on the associated clinical manifestations, OFC was suspected. Clinical exome sequencing revealed CDC73(+) c.687_688dupAG heterogenous pathogenic autosomal dominant mutation. Undiagnosed PHPT in mothers during pregnancy led to neonatal hypocalcaemic convulsions. With adequate supplementation, the infant recovered completely from transient congenital hypoparathyroidism. OFC is an important diagnosis to consider in a young patient with swelling of the neck and jaw. Simultaneous high levels of PTH and serum calcium should raise a high index of suspicion for OFC. Parathyroidectomy helps manage the biochemical abnormalities and causes regression of the jaw mass that causes facial disfigurement and attenuates the declining BMD. Children born to mothers with PHPT should be evaluated for neonatal hypoparathyroidism and supplemented appropriately to reduce the risk of hypocalcaemic manifestations that can be life-threatening. If the CDC73 mutation is detected, the offspring should be monitored for signs of PHPT due to the high probability of inheritance and parathyroid malignancy.

通常,原发性甲状旁腺功能亢进(PHPT)是由多腺增生、甲状旁腺癌或甲状旁腺瘤引起的。患者通常表现为骨骼表现,如低创伤性骨折。囊性纤维性骨炎(OFC)是晚期PHPT的一种典型但罕见的骨骼表现,目前报道的发病率不到2%。我们报告一例29岁的印度女性,分娩后20天出现股骨骨折和下颌骨OFC。下颌骨无痛性肿胀从妊娠第三个月开始逐渐加重。生化和放射学检查提示phpt相关OFC。切除三半甲状旁腺后,组织学显示良性囊性腺瘤及增生。根据相关临床表现,怀疑为OFC。临床外显子组测序显示CDC73(+) c.687_688dupAG异源致病性常染色体显性突变。未确诊的PHPT母亲在怀孕期间导致新生儿低钙性惊厥。通过适当的补充,婴儿从短暂的先天性甲状旁腺功能减退症完全恢复。OFC是一个重要的诊断考虑的年轻患者肿胀的颈部和颌骨。同时高水平的甲状旁腺激素和血清钙应该提高对OFC的怀疑指数。甲状旁腺切除术有助于控制生化异常,并导致颌骨块的退化,从而导致面部毁容和减缓下降的骨密度。患有PHPT的母亲所生的孩子应评估新生儿甲状旁腺功能低下,并适当补充以减少可能危及生命的低钙血症表现的风险。如果检测到CDC73突变,由于遗传和甲状旁腺恶性肿瘤的高概率,应监测后代是否有PHPT的迹象。
{"title":"A Case of Osteitis Fibrosa Cystica of the Mandible: A Rare Presentation during Pregnancy due to <i>CDC73</i> Mutation.","authors":"Pratibha Pawal, Anand Nikalje, Yash Chauhan, Premlata Varthakavi, Nikhil Bhagwat","doi":"10.15605/jafes.039.02.17","DOIUrl":"https://doi.org/10.15605/jafes.039.02.17","url":null,"abstract":"<p><p>Typically, primary hyperparathyroidism (PHPT) develops as a result of multiglandular hyperplasia, parathyroid cancer, or parathyroid adenoma. Patients usually present with skeletal manifestations such as low-trauma fractures. Osteitis fibrosa cystica (OFC) is a classic yet rare skeletal manifestation of advanced PHPT currently reported in less than 2% of patients. We present a case of a 29-year-old Indian female who presented with a femur fracture and mandibular OFC 20 days after delivery. The painless mandibular swelling gradually progressed from the third month of pregnancy. The biochemical and radiological investigations were indicative of PHPT-associated OFC. After the excision of the three-and-a-half parathyroid gland, histology revealed benign cystic adenomas and hyperplasia. Based on the associated clinical manifestations, OFC was suspected. Clinical exome sequencing revealed <i>CDC73</i>(+) c.687_688dupAG heterogenous pathogenic autosomal dominant mutation. Undiagnosed PHPT in mothers during pregnancy led to neonatal hypocalcaemic convulsions. With adequate supplementation, the infant recovered completely from transient congenital hypoparathyroidism. OFC is an important diagnosis to consider in a young patient with swelling of the neck and jaw. Simultaneous high levels of PTH and serum calcium should raise a high index of suspicion for OFC. Parathyroidectomy helps manage the biochemical abnormalities and causes regression of the jaw mass that causes facial disfigurement and attenuates the declining BMD. Children born to mothers with PHPT should be evaluated for neonatal hypoparathyroidism and supplemented appropriately to reduce the risk of hypocalcaemic manifestations that can be life-threatening. If the <i>CDC73</i> mutation is detected, the offspring should be monitored for signs of PHPT due to the high probability of inheritance and parathyroid malignancy.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"112-118"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intentional Hyperglycemia at work, Glycemic Control, Work-related Diabetes Distress and Work Ability among Workers with Diabetes. 工作中故意高血糖、血糖控制、与工作相关的糖尿病困扰和糖尿病工人的工作能力。
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-08-02 DOI: 10.15605/jafes.039.02.09
Samah Saleh Elhadidy, Abdel-Hady El-Gilany, Mohamed Roshdi Abdel Ghani Badawi, Aya Mohamed Elbialy

Background: Work life of individuals with diabetes differs from that of those without diabetes. Work may interfere with diabetes self-management tasks, resulting in intentional hyperglycemia at work (IHW) and poor glycemic control. Diabetes affects work productivity due to work-related diabetes distress (WRDD) and impaired work ability (WA).

Objectives: To estimate the prevalence and identify the predictors of always high, poor/very poor glycemic control, high WRDD and poor/moderate WA among workers with diabetes.

Methodology: A cross-sectional study was done at the Specialized Medical Hospital Mansoura University, which included 323 working patients with diabetes. They were subjected to personal interviews to collect socio-demographic data, occupational, diabetes and other pertinent medical histories. Questionnaires for measuring IHW, WRDD and WA were completed. Clinical and A1c data were obtained from their records.

Results: The prevalence of always high IHW, poor/very poor glycemic control, high WRDD and poor/moderate work ability was: 23.8%, 60.1%, 34.7% and 74.6%, respectively. The predictors of always high IHW were: 1) Below university education; 2) Treatment with insulin only or combined with oral drugs; and 3) High WRDD. The predictors of poor/very poor glycemic control were urban residence, always and almost high IHW. The predictors of high WRDD were mentallyrequiring jobs or both mentally- and physically-requiring jobs, duration of diabetes greater than 14 years and treatment with insulin. The predictors of poor/moderate WA were 'high' WRDD, 'almost high' and 'high a few times' IHW ratings.

Conclusions: Most of the studied population suffered mainly from poor/very poor glycemic control and poor/moderate work ability, while a lower proportion had high WRDD. This highlighted the need for workplace modifications and interventions to help workers with diabetes control their diabetes, improve their work ability and reduce WRDD to increase productivity.

背景:糖尿病患者的工作寿命与非糖尿病患者不同。工作可能会干扰糖尿病自我管理任务,导致工作时故意高血糖(IHW)和血糖控制不良。糖尿病由于工作相关的糖尿病困扰(WRDD)和工作能力受损(WA)而影响工作效率。目的:估计糖尿病工人的患病率,并确定血糖控制总是高、差/极差、高WRDD和差/中度WA的预测因素。方法:在曼苏拉大学专科医院进行了一项横断面研究,其中包括323名患有糖尿病的工作患者。他们接受了个人访谈,以收集社会人口数据、职业、糖尿病和其他相关病史。完成了IHW、WRDD和WA测量问卷。临床和糖化血红蛋白数据来自他们的记录。结果:常高IHW、血糖控制差/极差、WRDD高、工作能力差/中等的患病率分别为:23.8%、60.1%、34.7%和74.6%。高收入的预测因子有:1)大学学历以下;2)单用胰岛素或联合口服药物治疗;3) WRDD高。血糖控制差/非常差的预测因素是城市居住,总是和几乎高IHW。高WRDD的预测因子是精神要求高的工作或精神和体力要求高的工作,糖尿病病程超过14年,并接受胰岛素治疗。差/中等WA的预测因子为WRDD“高”、IHW“几乎高”和IHW“几倍高”。结论:研究人群以血糖控制较差/极差、工作能力较差/中等为主,WRDD较高的比例较低。这突出表明需要对工作场所进行改造和干预,以帮助糖尿病患者控制糖尿病,提高他们的工作能力,减少WRDD,以提高生产率。
{"title":"Intentional Hyperglycemia at work, Glycemic Control, Work-related Diabetes Distress and Work Ability among Workers with Diabetes.","authors":"Samah Saleh Elhadidy, Abdel-Hady El-Gilany, Mohamed Roshdi Abdel Ghani Badawi, Aya Mohamed Elbialy","doi":"10.15605/jafes.039.02.09","DOIUrl":"https://doi.org/10.15605/jafes.039.02.09","url":null,"abstract":"<p><strong>Background: </strong>Work life of individuals with diabetes differs from that of those without diabetes. Work may interfere with diabetes self-management tasks, resulting in intentional hyperglycemia at work (IHW) and poor glycemic control. Diabetes affects work productivity due to work-related diabetes distress (WRDD) and impaired work ability (WA).</p><p><strong>Objectives: </strong>To estimate the prevalence and identify the predictors of always high, poor/very poor glycemic control, high WRDD and poor/moderate WA among workers with diabetes.</p><p><strong>Methodology: </strong>A cross-sectional study was done at the Specialized Medical Hospital Mansoura University, which included 323 working patients with diabetes. They were subjected to personal interviews to collect socio-demographic data, occupational, diabetes and other pertinent medical histories. Questionnaires for measuring IHW, WRDD and WA were completed. Clinical and A1c data were obtained from their records.</p><p><strong>Results: </strong>The prevalence of always high IHW, poor/very poor glycemic control, high WRDD and poor/moderate work ability was: 23.8%, 60.1%, 34.7% and 74.6%, respectively. The predictors of always high IHW were: 1) Below university education; 2) Treatment with insulin only or combined with oral drugs; and 3) High WRDD. The predictors of poor/very poor glycemic control were urban residence, always and almost high IHW. The predictors of high WRDD were mentallyrequiring jobs or both mentally- and physically-requiring jobs, duration of diabetes greater than 14 years and treatment with insulin. The predictors of poor/moderate WA were 'high' WRDD, 'almost high' and 'high a few times' IHW ratings.</p><p><strong>Conclusions: </strong>Most of the studied population suffered mainly from poor/very poor glycemic control and poor/moderate work ability, while a lower proportion had high WRDD. This highlighted the need for workplace modifications and interventions to help workers with diabetes control their diabetes, improve their work ability and reduce WRDD to increase productivity.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"70-78"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Maternal Iodine Excess during Pregnancy on Neonatal Thyroid Function and Neurodevelopmental Status at 12 Weeks. 妊娠期母体碘过量对12周新生儿甲状腺功能和神经发育状况的影响。
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-08-27 DOI: 10.15605/jafes.039.02.12
Deepashree K Rao, Ankur Jindal, Aashima Dabas, Haseena Sait, Sangeeta Yadav, Seema Kapoor

Objective: This study aims to determine the effect of iodine excess in pregnant mothers on thyroid function, growth and neurodevelopment in the neonates when assessed at 12 weeks of age.

Methodology: This prospective study enrolled term neonates with birth weight >2500 gm of mothers having urine iodine concentration (UIC) ≥500 µg/L documented in the third trimester of the peripartum period. Neonatal TSH was collected by heel prick on dried blood spots within 24-72 hours of age and measured by time-resolved fluroimmunoassay. Neonates with TSH ≥11 mIU/L at birth were followed up at 2 and 12 weeks to monitor thyroid dysfunction, growth and development.

Results: A total of 2354 (n = 1575 in the delivery room) maternal urine samples were collected of which 598 (25.4%) had elevated UIC. Forty-nine (12.2%) neonates had TSH ≥11mIU/L on newborn screening of whom 18 and 3 neonates had residual elevated TSH at 2 and 12 weeks of life, respectively. Maternal iodine levels correlated weakly with TSH at 2 weeks (rho = 0.299; p = 0.037). No child required treatment for congenital hypothyroidism. Eight babies additionally had TSH >5 mIU/L at 12 weeks of life. The growth and development of babies with or without TSH elevation was comparable at three months (p >0.05).

Conclusion: Maternal iodine excess in pregnancy and peripartum period causes transient hyperthyrotropinemia in neonates that did not affect the growth and development at 3 months of age.

目的:本研究旨在确定孕妈妈碘过量对12周龄新生儿甲状腺功能、生长和神经发育的影响。方法:本前瞻性研究纳入围生期晚期尿碘浓度(UIC)≥500 μ g/L记录的出生体重为bb0 ~ 2500 gm的足月新生儿。新生儿TSH采集方法为24 ~ 72小时内干血点刺足采集,时间分辨荧光免疫法测定。出生时TSH≥11 mIU/L的新生儿分别于2周和12周随访,监测甲状腺功能障碍、生长发育情况。结果:共收集产妇尿液2354份(产房1575份),其中UIC升高598份(25.4%)。49例(12.2%)新生儿TSH≥11mIU/L,其中18例和3例分别在2周和12周时TSH残留升高。孕2周时母体碘水平与TSH呈弱相关(rho = 0.299;P = 0.037)。没有儿童需要治疗先天性甲状腺功能减退症。另外,8名婴儿在12周时的TSH水平为50 mIU/L。TSH升高或未升高的婴儿在3个月时的生长发育相当(p < 0.05)。结论:妊娠期和围生期母体碘过量可引起新生儿短暂性高甲状腺素血症,但不影响3月龄时的生长发育。
{"title":"Effect of Maternal Iodine Excess during Pregnancy on Neonatal Thyroid Function and Neurodevelopmental Status at 12 Weeks.","authors":"Deepashree K Rao, Ankur Jindal, Aashima Dabas, Haseena Sait, Sangeeta Yadav, Seema Kapoor","doi":"10.15605/jafes.039.02.12","DOIUrl":"https://doi.org/10.15605/jafes.039.02.12","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to determine the effect of iodine excess in pregnant mothers on thyroid function, growth and neurodevelopment in the neonates when assessed at 12 weeks of age.</p><p><strong>Methodology: </strong>This prospective study enrolled term neonates with birth weight >2500 gm of mothers having urine iodine concentration (UIC) ≥500 µg/L documented in the third trimester of the peripartum period. Neonatal TSH was collected by heel prick on dried blood spots within 24-72 hours of age and measured by time-resolved fluroimmunoassay. Neonates with TSH ≥11 mIU/L at birth were followed up at 2 and 12 weeks to monitor thyroid dysfunction, growth and development.</p><p><strong>Results: </strong>A total of 2354 (n = 1575 in the delivery room) maternal urine samples were collected of which 598 (25.4%) had elevated UIC. Forty-nine (12.2%) neonates had TSH ≥11mIU/L on newborn screening of whom 18 and 3 neonates had residual elevated TSH at 2 and 12 weeks of life, respectively. Maternal iodine levels correlated weakly with TSH at 2 weeks (<i>rho</i> = 0.299; <i>p</i> = 0.037). No child required treatment for congenital hypothyroidism. Eight babies additionally had TSH >5 mIU/L at 12 weeks of life. The growth and development of babies with or without TSH elevation was comparable at three months (<i>p</i> >0.05).</p><p><strong>Conclusion: </strong>Maternal iodine excess in pregnancy and peripartum period causes transient hyperthyrotropinemia in neonates that did not affect the growth and development at 3 months of age.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 2","pages":"27-32"},"PeriodicalIF":0.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Hyperparathyroidism during Pregnancy: Two Tales with Different Outcomes. 妊娠期原发性甲状旁腺功能亢进症:两个不同结果的故事
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-02-08 DOI: 10.15605/jafes.039.01.17
Yoon Doong Loh, Masliza Hanuni Mohd Ali

Primary hyperparathyroidism (PHPT) is rare in pregnancy. This condition is challenging to diagnose and manage due to the limited diagnostic and therapeutic options that are safe during pregnancy. If not diagnosed and managed in a timely manner, serious maternal and foetal complications may occur. We report two cases, one with surgical intervention and one without, to show the importance of timely surgical intervention and discuss the challenges in the management of PHPT in pregnancy.

原发性甲状旁腺功能亢进症(PHPT)在妊娠期非常罕见。由于在怀孕期间可以安全使用的诊断和治疗方法有限,因此这种疾病的诊断和治疗具有挑战性。如果不及时诊断和处理,可能会出现严重的母体和胎儿并发症。我们报告了两例病例,一例进行了手术干预,一例未进行手术干预,以说明及时手术干预的重要性,并讨论妊娠期 PHPT 的管理挑战。
{"title":"Primary Hyperparathyroidism during Pregnancy: Two Tales with Different Outcomes.","authors":"Yoon Doong Loh, Masliza Hanuni Mohd Ali","doi":"10.15605/jafes.039.01.17","DOIUrl":"10.15605/jafes.039.01.17","url":null,"abstract":"<p><p>Primary hyperparathyroidism (PHPT) is rare in pregnancy. This condition is challenging to diagnose and manage due to the limited diagnostic and therapeutic options that are safe during pregnancy. If not diagnosed and managed in a timely manner, serious maternal and foetal complications may occur. We report two cases, one with surgical intervention and one without, to show the importance of timely surgical intervention and discuss the challenges in the management of PHPT in pregnancy.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"115-119"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Gestational Diabetes Mellitus Knowledge Questionnaire (GDMKQ) among Filipino Patients in a Tertiary Medical Center. 在一家三级医疗中心的菲律宾患者中验证妊娠糖尿病知识问卷 (GDMKQ)。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-01-23 DOI: 10.15605/jafes.039.01.10
Hanah Go, Florence Rochelle Gan

Objectives: Gestational diabetes mellitus (GDM) is a common pregnancy complication with adverse fetal and maternal outcomes. Currently, there are only a few validated tools available that address knowledge in GDM. Recognition of the inconsistencies will provide an effective learning program to achieve optimal results. This study aimed at validating the "Gestational Diabetes Mellitus Knowledge Questionnaire" (GDMKQ).

Methodology: A cross-sectional validation study on GDMKQ among 51 GDM patients aged at least 18 years was conducted in the outpatient clinics of a tertiary hospital. Excluded were those with pre-existing diabetes. The questionnaire was submitted for peer review for translation to Filipino and back-translation. Concurrent validity, internal consistency and test-retest reliability of the questionnaire were undertaken as part of the validation process. Descriptive analysis was used for data elaboration by using SPSS v23.

Results: The Filipino version of GDMKQ demonstrated sensible content and face validity. As measured, respondents obtained higher total and domain scores with better knowledge levels of GDM compared to its English version. Overall adequate knowledge was observed among those married and college subgroups as compared to single women and those with secondary levels of education. The reliability of the questionnaire was calculated at 0.632 using the Kuder-Richardson 20. The test-retest scores using the Filipino-translated questionnaire have a Pearson correlation coefficient of 0.853 with moderate to good level of agreement with each other, and Cohen's kappa of 0.564 with an intra-class correlation coefficient of 0.828.

Conclusion: The Filipino-translated version of GDMKQ is a valid screening tool that assesses a patient's knowledge on gestational diabetes. Identifying the level of their understanding will enable clinicians to develop an individualized, effective learning program to improve pregnancy outcomes.

目的:妊娠期糖尿病(GDM)是一种常见的妊娠并发症,会对胎儿和产妇造成不良后果。目前,针对 GDM 知识的有效工具屈指可数。认识到这些不一致之处,就能提供有效的学习计划,以达到最佳效果。本研究旨在验证 "妊娠期糖尿病知识问卷"(GDMKQ):在一家三甲医院的门诊部对 51 名年龄在 18 岁以上的妊娠糖尿病患者进行了 GDMKQ 的横断面验证研究。已患糖尿病的患者除外。问卷已提交同行评审,以便翻译成菲律宾语并进行回译。作为验证过程的一部分,对问卷进行了并行有效性、内部一致性和重复测试可靠性验证。使用 SPSS v23.Results 对数据进行了描述性分析:菲律宾语版的 GDMKQ 具有合理的内容效度和表面效度。经测量,与英文版相比,受访者的总分和领域得分更高,对 GDM 的了解程度也更高。与单身女性和受过中等教育的女性相比,已婚女性和大学生群体对 GDM 的总体了解程度较高。根据 Kuder-Richardson 20 计算,问卷的可靠性为 0.632。使用菲律宾语翻译版问卷进行的重测得分的皮尔逊相关系数为 0.853,相互之间的吻合程度为中等至良好,科恩卡帕值为 0.564,类内相关系数为 0.828:菲律宾语翻译版 GDMKQ 是一种有效的筛查工具,可以评估患者对妊娠糖尿病的了解程度。确定患者的了解程度将有助于临床医生制定个性化、有效的学习计划,从而改善妊娠结局。
{"title":"Validation of the Gestational Diabetes Mellitus Knowledge Questionnaire (GDMKQ) among Filipino Patients in a Tertiary Medical Center.","authors":"Hanah Go, Florence Rochelle Gan","doi":"10.15605/jafes.039.01.10","DOIUrl":"10.15605/jafes.039.01.10","url":null,"abstract":"<p><strong>Objectives: </strong>Gestational diabetes mellitus (GDM) is a common pregnancy complication with adverse fetal and maternal outcomes. Currently, there are only a few validated tools available that address knowledge in GDM. Recognition of the inconsistencies will provide an effective learning program to achieve optimal results. This study aimed at validating the \"Gestational Diabetes Mellitus Knowledge Questionnaire\" (GDMKQ).</p><p><strong>Methodology: </strong>A cross-sectional validation study on GDMKQ among 51 GDM patients aged at least 18 years was conducted in the outpatient clinics of a tertiary hospital. Excluded were those with pre-existing diabetes. The questionnaire was submitted for peer review for translation to Filipino and back-translation. Concurrent validity, internal consistency and test-retest reliability of the questionnaire were undertaken as part of the validation process. Descriptive analysis was used for data elaboration by using SPSS v23.</p><p><strong>Results: </strong>The Filipino version of GDMKQ demonstrated sensible content and face validity. As measured, respondents obtained higher total and domain scores with better knowledge levels of GDM compared to its English version. Overall adequate knowledge was observed among those married and college subgroups as compared to single women and those with secondary levels of education. The reliability of the questionnaire was calculated at 0.632 using the Kuder-Richardson 20. The test-retest scores using the Filipino-translated questionnaire have a Pearson correlation coefficient of 0.853 with moderate to good level of agreement with each other, and Cohen's kappa of 0.564 with an intra-class correlation coefficient of 0.828.</p><p><strong>Conclusion: </strong>The Filipino-translated version of GDMKQ is a valid screening tool that assesses a patient's knowledge on gestational diabetes. Identifying the level of their understanding will enable clinicians to develop an individualized, effective learning program to improve pregnancy outcomes.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"18-25"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11163324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Accuracy of American College of Radiology Thyroid Imaging Reporting Data System: A Single-center Cross-sectional Study. 美国放射学会甲状腺成像报告数据系统的诊断准确性:单中心横断面研究。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 Epub Date: 2024-01-08 DOI: 10.15605/jafes.039.01.08
Pamela Ann Aribon, Emmylou Teope, Anna Lyn Egwolf, Maria Patricia Maningat

Objective: This study aims to evaluate the diagnostic accuracy of the American College of Radiology Thyroid Imaging Reporting Data System (ACR TI-RADS) in identifying nodules that need to undergo fine-needle aspiration biopsy (FNAB) and identify specific thyroid ultrasound characteristics of nodules associated with thyroid malignancy in Filipinos in a single tertiary center.

Methodology: One hundred seventy-six thyroid nodules from 130 patients who underwent FNAB from January 2018 to December 2018 were included. The sonographic features were described and scored using the ACR TI-RADS risk classification system, and the score was correlated to their final cytopathology results.

Results: The calculated malignancy rates for TI-RADS 2 to TI-RADS 5 were 0%, 3.13%, 7.14%, and 38.23%, respectively, which were within the TI-RADS risk stratification thresholds. The ACR TI-RADS had a sensitivity of 89.5% and specificity of 54%, LR + of 1.95 and LR - of 0.194, NPV of 97.7%, PPV of 19.1%, and accuracy of 58%.

Conclusion: The ACR TI-RADS may provide an effective malignancy risk stratification for thyroid nodules and may help guide the decision for FNAB among Filipino patients. The classification system may decrease the number of unnecessary FNABs for nodules with low-risk scores.

研究目的本研究旨在评估美国放射学会甲状腺成像报告数据系统(ACR TI-RADS)在确定需要进行细针穿刺活检(FNAB)的结节方面的诊断准确性,并确定菲律宾人在单一三级中心与甲状腺恶性肿瘤相关的结节的特定甲状腺超声特征:纳入2018年1月至2018年12月期间接受FNAB检查的130名患者的176个甲状腺结节。采用 ACR TI-RADS 风险分类系统对声像图特征进行描述和评分,并将评分与最终的细胞病理学结果进行关联:计算得出的TI-RADS 2至TI-RADS 5恶性率分别为0%、3.13%、7.14%和38.23%,均在TI-RADS风险分层阈值范围内。ACR TI-RADS 的灵敏度为 89.5%,特异度为 54%,LR + 为 1.95,LR - 为 0.194,NPV 为 97.7%,PPV 为 19.1%,准确度为 58%:ACR TI-RADS可对甲状腺结节进行有效的恶性风险分层,并有助于指导菲律宾患者做出FNAB的决定。该分类系统可减少对低风险评分结节进行不必要的 FNAB 的次数。
{"title":"Diagnostic Accuracy of American College of Radiology Thyroid Imaging Reporting Data System: A Single-center Cross-sectional Study.","authors":"Pamela Ann Aribon, Emmylou Teope, Anna Lyn Egwolf, Maria Patricia Maningat","doi":"10.15605/jafes.039.01.08","DOIUrl":"10.15605/jafes.039.01.08","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the diagnostic accuracy of the American College of Radiology Thyroid Imaging Reporting Data System (ACR TI-RADS) in identifying nodules that need to undergo fine-needle aspiration biopsy (FNAB) and identify specific thyroid ultrasound characteristics of nodules associated with thyroid malignancy in Filipinos in a single tertiary center.</p><p><strong>Methodology: </strong>One hundred seventy-six thyroid nodules from 130 patients who underwent FNAB from January 2018 to December 2018 were included. The sonographic features were described and scored using the ACR TI-RADS risk classification system, and the score was correlated to their final cytopathology results.</p><p><strong>Results: </strong>The calculated malignancy rates for TI-RADS 2 to TI-RADS 5 were 0%, 3.13%, 7.14%, and 38.23%, respectively, which were within the TI-RADS risk stratification thresholds. The ACR TI-RADS had a sensitivity of 89.5% and specificity of 54%, LR + of 1.95 and LR - of 0.194, NPV of 97.7%, PPV of 19.1%, and accuracy of 58%.</p><p><strong>Conclusion: </strong>The ACR TI-RADS may provide an effective malignancy risk stratification for thyroid nodules and may help guide the decision for FNAB among Filipino patients. The classification system may decrease the number of unnecessary FNABs for nodules with low-risk scores.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"39 1","pages":"61-68"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11166092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the ASEAN Federation of Endocrine Societies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1